Healthcare Data Monetization Market Outlook 2025-2030 | Innovations Fueling Life Sciences Research
Healthcare Data Monetization Market Overview:
The global healthcare
data monetization market is projected to expand at a CAGR of
around 15% over the forecast period. Growth is being fueled by rising
demand for real-world evidence (RWE), widespread adoption of electronic
health records (EHRs) and digital health ecosystems, the rapid increase in
large and complex healthcare datasets, and the growing emphasis on personalized
medicine supported by artificial intelligence and predictive analytics.
Additionally, continued investments in telehealth platforms and
remote-monitoring startups are strengthening market momentum. Despite this,
concerns surrounding data privacy, as well as persistent challenges related to
interoperability and a lack of standardized data formats, continue to impede
broader market advancement.
Year-End
Mega Sale: Get Up to 10% Off on All Market Research Reports!
Healthcare data monetization
involves leveraging health information to enhance operational and clinical
efficiencies or commercializing anonymized datasets to external stakeholders
for economic gain. As healthcare systems become increasingly digital, they
generate vast amounts of information from varied sources—including telemedicine
platforms, genomic databases, EHRs, wearables, imaging technologies, and
billing systems. By aggregating, anonymizing, and repurposing this information,
organizations can unlock insights that drive innovation, improve outcomes, and
create new revenue pathways across the healthcare value chain.
Rising importance of real-world
evidence
One of the primary forces accelerating the healthcare
data monetization market is the escalating reliance on real-world evidence.
Derived from everyday clinical practice, insurance claims, digital health
applications, wearables, and EHRs, RWE has reshaped how pharmaceutical and
biotech companies approach drug discovery, regulatory decision-making, and
post-market monitoring. The ongoing transition from volume-based to value-based
care aligns seamlessly with RWE, as both prioritize improved outcomes and cost
efficiency.
With chronic diseases such as diabetes and cancer on
the rise, RWE offers critical insights for long-term patient management. The
growing shift toward personalized therapeutics also demands expansive datasets
to tailor individualized treatments. This surge in data needs has prompted
pharmaceutical, biotech, and med-tech firms to commercialize anonymized
datasets for use in diagnostics, AI-driven decision support, and clinical
research.
Download Sample Copy: https://meditechinsights.com/healthcare-data-monetization-market/request-sample/
AI-driven insights shaping the next
growth phase
The market is increasingly embracing AI-enabled
platforms that deliver real-time insights instead of traditional,
fragmented data outputs. These advanced systems employ predictive analytics for
precise cohort analyses, comprehensive patient summaries, and analytic
modeling. Delivered through cloud infrastructures and API-based solutions,
these tools enable life sciences companies, payers, and researchers to securely
access actionable intelligence on demand. Healthcare organizations that
commercialize such insights are not only unlocking new revenue streams but also
strengthening their strategic position in a rapidly evolving digital health
landscape.
Recent market developments
The latest advancements in healthcare data monetization
emphasize secure data-sharing models, federated networks, and AI-enhanced
analytics that support deeper insights while prioritizing patient privacy.
Notable developments include:
- December 2024: Atropos Health introduced AI model-training
capabilities on the Atropos Evidence Network—one of the largest federated
healthcare data networks globally, encompassing more than 300 million
patient records. This enables pharmaceutical and life sciences companies
to develop, evaluate, and deploy AI models to identify underserved or
overlooked patient groups.
- October 2024: datma, Inc. launched datma.FED, a
two-sided marketplace designed to improve healthcare data accessibility
and monetization by connecting data custodians, such as hospitals and
reference laboratories, with pharmaceutical companies and research
organizations.
Competitive landscape
The healthcare data monetization industry features a
mix of established technology leaders and emerging innovators, including Oracle
Corporation, SAS Institute Inc., Salesforce, Particle Health, SAP SE,
Microsoft, Komodo Health, Snowflake, ThoughtSpot, and Tibco Software,
among others. Key competitive strategies include developing next-generation
analytics platforms, executing mergers and acquisitions, and expanding R&D
investment to support growing demand for data-driven healthcare intelligence.
Browse Report: https://meditechinsights.com/healthcare-data-monetization-market/
Global Healthcare Data
Monetization Market Segmentation
This report by Medi-Tech Insights provides the size
of the global healthcare data monetization market at the regional- and
country-level from 2023 to 2030. The report further segments the market based
on type, deployment type, and end-user.
Market Size & Forecast (2023-2030), By Type, USD
Million
·
Direct Data
Monetization
·
Indirect
Data Monetization
Market Size & Forecast (2023-2030), By Deployment
Type, USD Million
·
On-Premises
·
Cloud-based
Market Size & Forecast (2023-2030), By End-user, USD
Million
·
Pharma
& Biotech Companies
·
Healthcare
Providers
·
Healthcare
Payers
·
Med-tech
Companies
·
Others
Market Size & Forecast (2023-2030), By Region, USD
Million
·
North
America
o US
o Canada
·
Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe
·
Asia
Pacific
o China
o India
o Japan
o Rest of Asia Pacific
·
Latin
America
·
Middle East
& Africa
Related Report:
About Medi-Tech Insights ;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment